H3B-6545 is an oral, selective estrogen receptor covalent antagonist (SERCA) for the research of metastatic ER-positive, HER2-negative breast cancer[1][2].
Molecular Weight:
567.58
Purity:
99
CAS Number:
[2052130-80-8]
Formula:
C30H29F4N5O2
Target:
Estrogen Receptor/ERR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted